Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 6/27/2025 | 3/28/2025 | 12/27/2024 | |
|---|---|---|---|---|
| Revenue | $307 | $316 | $370 | $357 |
| % Growth | -2.7% | -14.6% | 3.5% | – |
| Cost of Goods Sold | $40 | $44 | $36 | $41 |
| Gross Profit | $268 | $272 | $334 | $316 |
| % Margin | 87.1% | 86.1% | 90.3% | 88.6% |
| R&D Expenses | $67 | $66 | $62 | $67 |
| G&A Expenses | $74 | $72 | $0 | $0 |
| SG&A Expenses | $164 | $158 | $160 | $164 |
| Sales & Mktg Exp. | $91 | $86 | $0 | $0 |
| Other Operating Expenses | $6 | -$1 | $0 | $0 |
| Operating Expenses | $238 | $224 | $222 | $231 |
| Operating Income | $30 | $48 | $112 | $85 |
| % Margin | 9.7% | 15.1% | 30.3% | 23.8% |
| Other Income/Exp. Net | $12 | $8 | $8 | $1 |
| Pre-Tax Income | $42 | $56 | $120 | $86 |
| Tax Expense | -$8 | $9 | $28 | $18 |
| Net Income | $49 | $46 | $92 | $68 |
| % Margin | 16.1% | 14.6% | 24.8% | 19% |
| EPS | 0.52 | 0.48 | 0.95 | 0.71 |
| % Growth | 8.3% | -49.5% | 33.8% | – |
| EPS Diluted | 0.51 | 0.48 | 0.94 | 0.7 |
| Weighted Avg Shares Out | 96 | 96 | 96 | 96 |
| Weighted Avg Shares Out Dil | 97 | 97 | 97 | 97 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $4 | $4 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $25 | $24 | $24 | $25 |
| EBITDA | $60 | $71 | $145 | $111 |
| % Margin | 19.7% | 22.7% | 39.1% | 31.2% |